Guided Therapeutics, Inc. (GTHP)
Stock Price: $0.780 USD
-0.010 (-1.27%)
Updated May 4, 2021 4:00 PM EDT - Market closed
| Market Cap | 10.21M |
| Revenue (ttm) | 102,000 |
| Net Income (ttm) | n/a |
| Shares Out | 13.30M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 4 |
| Last Price | $0.780 |
| Previous Close | $0.790 |
| Change ($) | -0.010 |
| Change (%) | -1.27% |
| Day's Open | 0.695 |
| Day's Range | 0.690 - 0.780 |
| Day's Volume | 4,203 |
| 52-Week Range | - |
News
There are no news available yet.
About GTHP
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 199... [Read more...]
| Industry Medical Devices | IPO Date Jul 1, 1997 |
| CEO Gene Cartwright | Employees 6 |
| Stock Exchange OTCMKTS | Ticker Symbol GTHP |